HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Stamulumab

an antibody designed to bind to and inhibit the activity of myostatin (growth differentiation factor 8); it is being tested for the treatment of Duchenne muscular dystrophy
Also Known As:
MYO-029; human recombinant immunoglobulin G1 anti-GDF8 monoclonal antibody
Networked: 5 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Sunada, Yoshihide: 3 articles (11/2011 - 11/2006)
2. Amato, Anthony A: 2 articles (01/2009 - 05/2008)
3. Walsh, Ronan: 1 article (01/2009)
4. Krivickas, Lisa S: 1 article (01/2009)
5. Eagle, Michelle: 1 article (05/2008)
6. Bushby, Katharine: 1 article (05/2008)
7. Wagner, Kathryn R: 1 article (05/2008)
8. Fleckenstein, James L: 1 article (05/2008)
9. Csimma, Cristina: 1 article (05/2008)
10. Pestronk, Alan: 1 article (05/2008)

Related Diseases

1. Muscular Dystrophies (Muscular Dystrophy)
2. Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
3. Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
4. Hypersensitivity (Allergy)

Related Drugs and Biologics

1. Myostatin
2. Neutralizing Antibodies
3. Collagen
4. Follistatin
5. Small Interfering RNA (siRNA)
6. RNA (Ribonucleic Acid)